Index tracked: Solactive SARON Daily Total Return Index
TER
0.10%+ trans. 0.00%
Fund size
3 m EUR
Tracking difference
—not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Synthetic (swap)
Income
Accumulating
Launch 29 Oct 2025 · costs from the KID as of 2 Sept 2026 · 522 securities held
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The investment objective of the Sub-Fund is to reflect the performance of the euro short-term rate (“€STR”) compounded rate (the “Benchmark Index”) and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Benchmark Index. The anticipated level of the tracking error, under normal market conditions is indicated in the prospectus of the Sub-Fund. The euro short-term rate (€STR) reflects the wholesale euro unsecured overnight borrowing costs of banks located in the Euro…
Performance since series start (in euro) — base 100
25 Nov 2025 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
High 104 (9 Mar 2026) · low 99 (8 Sept 2026) · last 99. Past performance is not indicative of future results.
RebalixSMCH · LU3168133059 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years
Not honestly computable: hedged class: the issuer’s published index is unhedged — the gap would measure the exchange rate, not replication. We don’t show it
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 1 Sept 2026 · 522 securities · top-10 weight = 36.8%
The live sheet, always up to date rebalix.com/en/etf/LU3168133059 Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.